{
  "nctId": "NCT04323514",
  "briefTitle": "Use of Ascorbic Acid in Patients With COVID 19",
  "officialTitle": "Use of Ascorbic Acid in Patients With COVID 19",
  "protocolDocument": {
    "nctId": "NCT04323514",
    "filename": "Prot_SAP_ICF_000.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2020-03-12",
    "uploadDate": "2020-03-24T05:48",
    "size": 249289,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04323514/document/Prot_SAP_ICF_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 500,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2020-03-13",
    "completionDate": "2021-03-13",
    "primaryCompletionDate": "2021-03-13",
    "firstSubmitDate": "2020-03-18",
    "firstPostDate": "2020-03-26"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* In case of doubt of interstitial pneumonia with indications for intubation\n* Positive swab test of SARS-CoV-2\n* Interstitial pneumonia\n* Signature of informed consent\n\nExclusion Criteria:\n\n* Unsigned informed consent\n* Negative swab test of SARS-CoV-2",
    "healthyVolunteers": false,
    "sex": "ALL",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "In-hospital mortality",
        "description": "Change of hospital mortality",
        "timeFrame": "72 hours"
      }
    ],
    "secondary": [
      {
        "measure": "PCR levels",
        "description": "Reduction of PCR levels \\> 50% in comparison with PCR levels at the admission, within 72 hours after the administration",
        "timeFrame": "72 hours"
      },
      {
        "measure": "Lactate clearance",
        "description": "Change of the lactate clearance",
        "timeFrame": "72 hours"
      },
      {
        "measure": "Hospital stay",
        "description": "Change of hospital stay days",
        "timeFrame": "72 hours"
      },
      {
        "measure": "Symptoms",
        "description": "Resolution of symptoms (Fever, Cough, Shortness of breath or difficulty breathing)",
        "timeFrame": "72 hours"
      },
      {
        "measure": "Positive swab",
        "description": "Change of duration of positive swab (nasopharynx and throat)",
        "timeFrame": "72 hours"
      },
      {
        "measure": "Tomography imaging",
        "description": "Resolution of tomography imaging (example, patches located in the subpleural regions of the lung)",
        "timeFrame": "72 hours"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 6,
      "otherCount": 0,
      "totalCount": 7
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 44,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-21T22:34:07.881Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}